Skip to main content

Change location

You are currently on the Canada (English) website

My country is not on the list

Global

  • Bracco.com (English)

Asia

  • China (中文)
  • Japan (日本語)
  • South Korea (한국어)

Americas

  • Brazil (Português)
  • Canada (English)
  • Mexico (English)
  • Canada (Français)
  • USA (English)

Europe

  • Austria (English)
  • Belgium (English)
  • Czech Republic (English)
  • Denmark (English)
  • Finland (English)
  • France (Français)
  • Germany (Deutsch)
  • Iceland (English)
  • Italy (Italiano)
  • Luxembourg (English)
  • Norway (English)
  • Poland (English)
  • Slovakia (English)
  • Sweden (English)
  • Switzerland (English)
  • The Netherlands (English)
  • UK (English)
  • Careers
  • Media and News
  • Get in touch
    • Canada (English)
  • Home
  • we are bracco
    We are Bracco

    Welcome to a World of contrasts

    • Our businesses
    • Purpose and values
    • Our history
    • Our Foundation
    • Responsibility and Ethical conduct
  • Our Portfolio

    Proven offerings for a proven difference

    • X-ray/CT
      • Contrast agents

        • Gastrografin
        • ISOVUE
      • Fluoroscopy
        • E-Z-HD
        • E-Z-PAQUE
        • Liquid POLIBAR PLUS
        • Varibar
      • Medical devices

        • Protoco2l Touch
        • CT Exprès 3D
        • EmpowerCTA+
    • MRI
      • Contrast agents

        • MultiHance
        • ProHance
      • Medical Devices

        • EmpowerMR
    • Ultrasound
      • Contrast agents

        • SonoVue
    • Nuclear medicine
      • Contrast agents

        • Choletec
        • Kinevac
    • Interventional cardiology
      • Contrast agents

        • ISOVUE
      • Medical devices

        • ACIST CVi
        • ACIST HDi
        • ACIST RXi
    • Digital solutions
    • Oncology
    • Cardiology
  • Woman looking into microscope
    Innovation

    A deep dive into our R&D progress

    • Digital future
    • R&D
    • The Bracco sites
    • Scientific heritage and patents
  • knowledge
    Knowledge

    Current activities and future opportunities

    • E-learning
    • Partnerships in education
    • Events
  • Ceriano Laghetto
    Sustainability

    Our game plan and goals for a better world

    • Our sustainability pillars
    • Governance and transparency
    • Sustainability report
  • Our Stories
  1. Home
  2. Our Portfolio
  3. X-ray/CT
  4. Fluoroscopy

  5. Varibar

VARIBAR®

 

 

Liquid VARIBAR®, barium sulfate oral suspension is licensed by Health Canada as Natural Health Products.

 

VARIBAR (barium sulfate) is a suite of standardized-viscosity oral contrast preparations for modified barium swallow (MBS) studies.

VARIBAR products for MBS studies... remove uncertainty from the mix with standard formulations1-4,7-11

 

The only premixed, premeasured, and precise barium formulations for MBS studies that may:

 

  • Reduce preparation time and wasted materials
     
  • Avoid undesirable coating inherent to traditional GI barium preparations2-5
     
  • Support high-quality imaging3
     
  • Enable reproducible results2-5

 

Simple to use, the VARIBAR products are the only barium products with standardized barium concentration and viscosity ranges, which come premeasured and premixed*, eliminating the potential for variability in results.

 

VARIBAR products provide unmatched convenience with reproducible results. To ensure every issue was addressed, the VARIBAR products were developed in cooperation with speech language pathologists.

 

 

COATING FACTOR

VARIBAR products are specifically formulated with the minimal coating properties necessary to clearly visualize the dynamic swallowing process. Other barium contrast agents are formulated to maximize the mucosal coating needed for standard GI studies.

 

 

UNIFORM OPACIFICATION

Uniform opacification is important for consistent visualization. VARIBAR products offer a standard 40% w/v ratio of barium sulfate concentration across the product line, helping to ensure a uniform density in each product. In turn, you get the same visualization from each swallowing event, test after test, no matter what viscosity level.

 

Standardized viscosities help eliminate the unpredictability of varied barium preparations.
ProductViscosity
VARIBAR® THIN LIQUID (barium sulfate) for oral suspension< 15 cps
VARIBAR® N (barium sulfate) oral suspension300 cps
VARIBAR® TH (barium sulfate) oral suspension1500 cps
VARIBAR® H (barium sulfate) oral suspension3000 cps
VARIBAR® P (barium sulfate) oral pasteN/A

 

✝VARIBAR THIN LIQUID (barium sulfate) for oral suspension is supplied as a powder and constituted to a standard volume with water.

 

 

TASTE & TEXTURE

Patient acceptance is always a concern when dealing with MBS studies. Some barium preparations taste unpleasant, and resistance among patients is high, possibly compromising swallowing.

 

With VARIBAR products, each viscosity is formulated to provide pleasant, easily tolerated flavors, textures and consistencies to help elicit normal salivation and a more natural swallowing action. The pleasing apple and vanilla flavors help increase patient acceptance and compliance.

 

 

PREPARATION TIME & WASTE

VARIBAR products are ready to use*. This eliminates the need to mix liquids with barium powders, pastes, and thickening agents. Your preparation time and overall waste of materials are reduced, as are expenditures over time.

 

 

ONE STANDARD. LESS UNCERTAINTY.

With standardized barium concentration and viscosity ranges, VARIBAR products reduce uncertainty, provide more consistent results, and increase patient acceptance.

 

 

THE IMPORTANCE OF STANDARDIZATION

Universal standards for swallowing evaluation, measurement and reporting methods currently don’t exist, leading many to see the MBS study as subjective.

 

The general consensus among healthcare professionals is that there has been no universally accepted, reliable, and clinically practical method for capturing swallowing impairment and comparing the results of MBS studies between clinics, research laboratories, and pre- and post-treatment testing. It is critical to develop a consistent method of testing to provide increased continuity and uniformity in MBS studies. VARIBAR products can help standardize testing, unlike anything else available today.

 

✝VARIBAR THIN LIQUID (barium sulfate) for oral suspension is supplied as a powder and constituted to a standard volume with water.

 

 

*VARIBAR THIN LIQUID (barium sulfate) for oral suspension is supplied as a powder and constituted to a standard volume with water.

 

 

1. Hazelwood, R.J., Armeson, K.E., Hill, E.G., Bonila, H.S., Martin-Harris, B. (2017). Identification of swallowing tasks from a modified barium swallow study that optimize the detection of physiologic impairment. Journal of Speech, Language and Hearing Research, 1-9. Doi.org/10.1044/2017_JSLHR-S-16-0117. 2. Robbins J, Nicosia M, Hind JA, Gill GD, Blanco R, Logemann J. Defining physical properties of fluids for dysphagia evaluation and treatment. ASHA, Special Interest Division 13. Swallowing and Swallowing Disorders (Dysphagia) Newsletter. 2002;11(2):16-19. 3. Steele CM, Barbon C, Namasivayam A. Best Practices in Videofluoroscopy. Dysphagia Cafe. Accessed June 10, 2016. 4. Hind J, Divyak E, Zielinski J, et al. Comparison of standardized bariums with varying rheological parameters on swallowing kinematics in males. J Rehabil Res Dev. 2012;49(9):1399 1401. 5. Steele CM, Molfenter SM, Péladeau-Pigeon M, Stokely S. Challenges in preparing contrast media for videofluoroscopy. Dysphagia. 2013;28(3):464-467. doi:10.1007/s00455-013-9476-7 6. Martin-Harris, B., (2015) Standardized Training in Swallow Physiology – Evidence-Based Assessment Using the Modified Barium Swallow Impairment Profile (MBSImP) Approach. Gaylord, MI, Northern Speech Services. 7. VARIBAR® THIN LIQUID (barium sulfate) for oral suspension full Prescribing Information. Monroe Twp., NJ: Bracco Diagnostics Inc.; May 2019. 8. VARIBAR® NECTAR (barium sulfate) oral suspension full Prescribing Information. Monroe Twp., NJ: Bracco Diagnostics Inc.; February 2020 9. VARIBAR® THIN HONEY (barium sulfate) oral suspension full Prescribing Information. Monroe Twp., NJ: Bracco Diagnostics Inc.; January 2018. 10. VARIBAR® HONEY (barium sulfate) oral suspension full Prescribing Information. Monroe Twp., NJ: Bracco Diagnostics Inc.; March 2018. 11. VARIBAR® PUDDING (barium sulfate) oral paste full Prescribing Information. Monroe Twp, NJ: Bracco Diagnostics Inc.; Oct. 2016.

 

 

Indications and Usage:

 

VARIBAR® TH (barium sulfate) oral suspension, VARIBAR® N (barium sulfate) oral suspension and VARIBAR® THIN LIQUID (barium sulfate) for oral suspension, are indicated for use in modified barium swallow examinations to evaluate the oral and pharyngeal function and morphology in adult and pediatric patients. VARIBAR® H (barium sulfate) oral suspension and VARIBAR® P (barium sulfate) oral paste are indicated for use in modified barium swallow examinations to evaluate the oral and pharyngeal function and morphology in adult and pediatric patients 6 months of age and older. 

 

 

IMPORTANT SAFETY INFORMATION:

 

For oral administration. This product should not be used in patients with known or suspected perforation of the GI tract, known obstruction of the GI tract, high risk of aspiration, or hypersensitivity to barium sulfate products. Rarely, severe allergic reactions of anaphylactoid nature have been reported following administration of barium sulfate contrast agents. Aspiration may occur during the modified barium swallow examination, monitor the patient for aspiration.

 

 

VARIBAR is manufactured by E-Z-EM Canada Inc., Montreal, QC H1J 2Z4.

 

VARIBAR is a registered trademark of E-Z-EM, Inc.

1. Hazelwood, R.J., Armeson, K.E., Hill, E.G., Bonila, H.S., Martin-Harris, B. (2017).

Identification of swallowing tasks from a modified barium swallow study that optimize the detection of physiologic impairment.

Journal of Speech, Language and Hearing Research, 1-9. Doi.org/10.1044/2017_JSLHR-S-16-0117.

 

Read more

 

 

2. Robbins J, Nicosia M, Hind JA, Gill GD, Blanco R, Logemann J.

Defining physical properties of fluids for dysphagia evaluation and treatment. ASHA, Special Interest Division 13.

Swallowing and Swallowing Disorders (Dysphagia) Newsletter. 2002;11(2):16-19.

 

Read more
 

 

3. Steele CM, Barbon C, Namasivayam A.

Best Practices in Videofluoroscopy. Dysphagia Cafe.

Accessed June 10, 2016.
 

Read more

 

 

4. Hind J, Divyak E, Zielinski J, et al.

Comparison of standardized bariums with varying rheological parameters on swallowing kinematics in males.

J Rehabil Res Dev. 2012;49(9):1399 1401.

 

Read more

 

 

5. Steele CM, Molfenter SM, Péladeau-Pigeon M, Stokely S.

Challenges in preparing contrast media for videofluoroscopy.

Dysphagia. 2013;28(3):464-467. doi:10.1007/s00455-013-9476-7

 

Download PDF

 

 

6. Martin-Harris, B., (2015)

Standardized Training in Swallow Physiology – Evidence-Based Assessment Using the Modified Barium Swallow Impairment Profile (MBSImP) Approach.

Gaylord, MI, Northern Speech Services.

Please consult Prescribing Information for VARIBAR (barium sulfate) for oral suspension by visiting the Licensed Natural Health Products Database (LNHPD) on Health Canada website or contact us:

 

https://health-products.canada.ca/lnhpd-bdpsnh/search-recherche.do#wb-auto-6 

  • Is VARIBAR® (barium sulfate) a multi-use product?
    Yes. Well-known current restrictions to multi-dosing apply to parenteral products. VARIBAR products are for oral use, and their containers are resealable. There are no specific protocols as to how much of each VARIBAR product preparation is used with any one patient; it will depend on the individual healthcare practitioner and patient requirements.
     
  • What is the difference between VARIBAR® H (barium sulfate) oral suspension and VARIBAR® TH (barium sulfate) oral suspension? 
    VARIBAR H (barium sulfate) oral suspension has a higher viscosity range than the VARIBAR TH (barium sulfate) oral suspension. VARIBAR TH (barium sulfate) oral suspension measures 800-1800 cps and VARIBAR H (oral suspension) measures 2500-3500 cps.
     
  • What is the in-use stability or storage of the VARIBAR products?
    The in-use stability or storage of the VARIBAR products under controlled conditions is as follows:

 

ProductIn-use Stability or Storage
VARIBAR® N (barium sulfate) oral suspensionUp to 21 days at controlled room temperature***
VARIBAR® TH (barium sulfate) oral suspensionUp to 21 days at controlled room temperature***
VARIBAR® H (barium sulfate) oral suspensionUp to 21 days at controlled room temperature***
VARIBAR® P (barium sulfate) oral pasteUp to 21 days at controlled room temperature***
VARIBAR® THIN LIQUID (barium sulfate) for oral suspension*Following reconstitution, 72 hours under refrigerated conditions***

 

All unopened VARIBAR products have a shelf life of 24 months from the date of manufacture. Any questions regarding the in-use stability of VARIBAR products can be answered by calling the Bracco Professional Services Department at 1-800-257-5181 (Option 2) or by email at [email protected] 

 

  • Do VARIBAR products come in different flavors?
    VARIBAR® THIN LIQUID (barium sulfate) for oral suspension, VARIBAR®N (barium sulfate) oral suspension, VARIBAR® TH (barium sulfate) oral suspension and VARIBAR® H (barium sulfate) oral suspension are formulated with a pleasing apple flavor for patient compliance. VARIBAR® P oral paste is formulated with a pleasing vanilla flavor for patient compliance. 
     
  • Is there a Bracco Diagnostics representative available to discuss or answer questions regarding VARIBAR products?
    Yes, we have VARIBAR product specialists available Monday-Friday, 8 AM - 5 PM (CST). 1-800-631-5245 (x7519), or please email us at [email protected]

 

*VARIBAR THIN LIQUID (barium sulfate) for oral suspension is supplied as a powder and constituted to a standard volume with water.

**VARIBAR products are standard formulations.

***According to Health Canada NHP approved Prescribing Information for VARIBAR products.

 

ProductProduct SKUInternal CodeDescription
VARIBAR THIN LIQUIDD105CAN705771<15 cPs, 81% w/v, 148g (24/box)
VARIBAR PD125CAN705772Pudding, 40% w/v, 230mL (per tube)
VARIBAR HD122CAN7057733000 cPs, 40% w/v, 250mL (12/box)
VARIBAR THD121CAN7057741500 cPs, 40% w/v, 250mL (12/box)
VARIBAR ND115CAN705775300 cPs, 40% w/v, 240mL (12/box)

PRODUCTS & SERVICES

 

If you have any questions regarding any Bracco Imaging products or require Service and Support for our equipment.

 

[email protected] 

PROFESSIONAL SERVICES

 

The Professional Services Group is available to assist health care professionals with requests for scientific or medical information about Bracco Imaging products.

 

[email protected]

CUSTOMER SERVICE/ORDER DESK

 

If you need to place an order:

 

[email protected]/[email protected]

Contact us


Please fill out the form below and we will get back to you.

Different countries may have specific processes in place to handle reports of adverse reactions. To report an adverse reaction related to Bracco products, you can find specific contacts and information selecting the page "Pharmacovigilance" of your country.

I have read and I agree with the Bracco Privacy Policy

* I have read the BraccoHealthCare Professionals Privacy Notice and I consent to the processing of my personal data allowing Bracco Imaging SpA (Data Controller) to conduct its business or scientific operations and contact me with promotional communication through email, SMS, and other digital and offline channels, such as mobile apps and social media.

Please login to DocCheck
to view our products

Register here Forgot your password?

The Bracco Group is an international group of highly specialized companies.
We are an active part of the healthcare sector, and a global leader in diagnostic imaging.

  • We are Bracco
  • Our Portfolio
  • Innovation
  • Knowledge
  • Sustainability
  • Our Stories
  • Pharmacovigilance
  • Data Protection

Connect with us

Via Egidio Folli 50
20134 Milan, Italy
Phone + 39 02 2177.1

  • Terms of Use
  • Privacy Policy
  • Cookie Policy
  • Imprint
  • for Bracco VPN users

Bracco Copyright © 2025 | Registered office: Via E. Folli, 50, 20134 Milano, Italy | Share Capital € 104.000.000 f.p. | VAT Milan Comp. Reg. n. 00825120157 | Milan REA n. 348182